• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Dis Now . Digital severity scoring and viral metagenomics: A feasibility study on integrated diagnosis of pediatric influenza-like illness

tetano

Editor, Senior Moderator
Infect Dis Now


. 2025 Dec 6:105223.
doi: 10.1016/j.idnow.2025.105223. Online ahead of print. Digital severity scoring and viral metagenomics: A feasibility study on integrated diagnosis of pediatric influenza-like illness

Patrick E Obermeier[SUP] 1 [/SUP], Maren Alchikh[SUP] 1 [/SUP], Xiaolin Ma[SUP] 2 [/SUP], Janine Reiche[SUP] 2 [/SUP], Brunhilde Schweiger[SUP] 2 [/SUP], Barbara A Rath[SUP] 3 [/SUP]



Affiliations
Abstract

Introduction: Metagenomic next-generation sequencing (mNGS) holds promise for identifying diverse pathogens in complex cases of influenza-like illness (ILI). Interpreting results requires comprehensive clinical context. We aimed to explore the feasibility of an integrated diagnostic approach by linking shotgun viral mNGS with standardized clinical data for unbiased ascertainment and hypothesis generation in pediatric ILI patients.
Patients and methods: We studied a cohort of 6,073 pediatric ILI patients (mean age 3.1 years, range 0-18.8 years), assessed using the VIVI ScoreApp for immediate computation of Disease Severity and Risk Factor Scores. Nasopharyngeal samples were tested for nine respiratory viruses by PCR. In a nested pilot feasibility study, we linked the clinical dataset of 100 ILI patients with neurological complications (mean age 3.9 years, range 0-17.8 years) to additional viral mNGS. PCR and mNGS were compared by agreement rates and Cohen's κ for inter-method reliability.
Results: In the pilot feasibility study, the mean VIVI Disease Severity Score was above the cohort average (>67th percentile, p < 0.0001), with 'age < 2 years' as the most prevalent risk factor (n = 44/100). mNGS identified 15 viruses, expanding the range of viral identifications by six viruses compared to PCR. Linking VIVI Scores with mNGS-discovered viruses suggested high disease severity. Sensitivity of mNGS was relatively low; overall agreement with PCR was 77-98 % and overall reliability was 'moderate' (κ scores of 0.1-0.85).
Conclusions: Digital surveillance tools can successfully integrate with mNGS to capture complex clinical patterns and generate data-driven hypotheses. Large-scale investigation and technical refinement are warranted.

Keywords: Digital surveillance; Influenza-like illness; Metagenomics; Precision medicine; Respiratory tract infection.

 
Back
Top